Laser ablation of complex perianal fistulas preserves continence and is a rectum-sparing

Bodzin, Jason H.
July 1998
American Surgeon;Jul1998, Vol. 64 Issue 7, p627
Academic Journal
Presents a review of the inflammatory bowel disease surgical database of the author for Crohn's disease (CD) patients who had a surgical approach to perianal fistula disease. Effectiveness of laser ablation of complex perianal fistulas; Assessment of the quality of life of the patients; Effectiveness of the technique in preserving spinchter function.


Related Articles

  • Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Sciaudone, Guido; Di Stazio, Crescenzo; Limongelli, Paolo; Guadagni, Ilaria; Pellino, Gianluca; Riegler, Gabriele; Coscione, Paolo; Selvaggi, Francesco // Canadian Journal of Surgery;Oct2010, Vol. 53 Issue 5, p299 

    Background: The aim of this study was to compare the outcomes of the management of perianal fistulas in Crohn disease between infliximab, surgery or a combination of surgery and infliximab. Methods: We prospectively subdivided 35 consecutive patients with Crohn disease with complex perianal...

  • Pouch function and quality of life after successful management of pouch-related septic complications in patients with ulcerative colitis. Mennigen, Rudolf; Senninger, Norbert; Bruewer, Matthias; Rijcken, Emile // Langenbeck's Archives of Surgery;Jan2012, Vol. 397 Issue 1, p37 

    Purpose: Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis is associated with pouch-related septic complications (PRSC) in 10% of patients. This study questioned if PRSC have a negative impact on pouch function and quality of life. Patients and methods:...

  • Inflammatory Bowel Disorders.  // Current Medical Literature: Gastroenterology;2010, Vol. 29 Issue 4, p105 

    The article presents expert commentaries on various studies on inflammatory bowel disorders. A study from Israel and published in "Gut," demonstrated that intravenous semapimod hydrochloride (HCl) is not clinically useful for the treatment of moderate to severe Crohn's disease. It relates a...

  • Crohn's disease with fistulae involving joints. Shreeve, D. R.; Ormerod, L. P.; Dunbar, E. M. // Journal of the Royal Society of Medicine;Dec1982, Vol. 75 Issue 12, p946 

    Two cases of Crohn's disease with unusual manifestations of fistulae involving joints are reported. One case with a fistula from the rectum through the pelvis presented with an abscess adjacent to the left hip joint. The second presented acutely with inflammation and swelling of the right thigh...

  • Oral Spherical Adsorptive Carbon for the Treatment of Intractable Anal Fistulas in Crohn's Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Fukuda, Yoshihiro; Takazoe, Masakazu; Sugita, Akira; Kosaka, Tadashi; Kinjo, Fukunori; Otani, Yoshimasa; Fujii, Hisao; Koganei, Kazutaka; Makiyama, Kazuya; Nakamura, Toshio; Suda, Takeyasu; Yamamoto, Shojiro; Ashida, Toshifumi; Majima, Akira; Morita, Norikazu; Murakami, Kazunari; Oshitani, Nobuhide; Takahama, Kazuya; Tochihara, Masahiro; Tsujikawa, Tomoyuki // American Journal of Gastroenterology;Jul2008, Vol. 103 Issue 7, p1721 

    OBJECTIVES: Anal fistulas are common in individuals with Crohn's disease (CD). We sought to evaluate the efficacy of oral spherical adsorptive carbon (AST-120) (Kremezin®; Kureha Corporation, Tokyo, Japan) for the treatment of intractable anal fistulas in patients with CD. METHODS: In this...

  • Management of perianal Crohn's disease. Hobbiss, J. H.; Schofield, Philip F. // Journal of the Royal Society of Medicine;Jun1982, Vol. 75 Issue 6, p414 

    Symptomatic anal disease (excluding skin tags) was observed in 49 out of 151 successive patients treated for Crohn's disease. Two main types of anal disease were encountered: anal ulceration (23 patients) and anal abscesses and fistulae (26 patients). The ulcer group rarely required local...

  • Perioperative adjuvant therapy with infliximab in complicated anal crohn’s disease. Kraemer, M.; Kirschmeier, A.; Marth, T. // International Journal of Colorectal Disease;Oct2008, Vol. 23 Issue 10, p965 

    Infliximab may represent an adjuvant to surgical therapy in patients with severe anal Crohn’s disease as it has been shown to affect rapid remissions in a proportion of cases. Nineteen patients underwent infliximab therapy 5 mg/kg perioperatively to scheduled anal reconstructive surgery...

  • Macrophage-Derived IL-18 Targeting for the Treatment of Crohn's Disease. T. Kanai; K. Uraushihara; T. Totsuka; A. Okazawa; T. Hibi; S. Oshima; T. Miyata; T. Nakamura; M. Watanabe // Current Drug Targets - Inflammation & Allergy;Jun2003, Vol. 2 Issue 2, p131 

    Crohn's disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-a (TNF-a), macrophage infiltrating...

  • Crohn's disease, Crohn disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p546 

    An encyclopedia entry for "Crohn's disease" and "Crohn disease," which refer to an inflammatory bowel disease, is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics